Dass-167 ((free)) Jun 2026

The identification of DASS-167 as a potent inhibitor of the SARS-CoV-2 virus has significant implications for the treatment of COVID-19. Future research will focus on optimizing the pharmacokinetics and safety of DASS-167, as well as evaluating its efficacy in clinical trials. The development of DASS-167 as a therapeutic agent may provide a much-needed treatment option for patients with COVID-19, particularly those who are resistant or intolerant to existing therapies.

In a rare move, the LTA listened. Just 11 days after the initial announcement, they reversed the decision. Instead of being axed entirely, Service 167 was saved, though it now operates at 30-minute intervals DASS-167

The neon lights fade back in. 167 sits alone in the aftermath, completely serene. The Architect looks at his monitors, utterly defeated. She didn't break; she transcended. A final lingering shot of her eyes hints that she is no longer under the Cartel's control. The identification of DASS-167 as a potent inhibitor